Surreptitious drug use by patients in a panic disorder study

Abstract
In a double-blind, placebo-controlled trial comparing alprazolam and imipramine for panic disorder, serum analysis revealed that a substantial proportion of the patients took explicitly prohibited anxiolytic medication. Excluding these patients changed the results.

This publication has 6 references indexed in Scilit: